Parathyroid carcinoma is an uncommon cause of PTH-dependent hypercalcemia. The
collective published experience with this rare neoplasm has provided a distinctive clinical …

Parathyroid carcinoma is a rare cause of primary hyperparathyroidism. However, to our best
knowledge, at least 163 cases of functioning parathyroid carcinoma appeared in the English …

Analysis of 286 cases of parathyroid carcinoma accessioned in the National Cancer Data
Base between 1985–1990 suggests a substantial proportion of patients fail to undergo …

Purpose. Because parathyroid carcinoma is rare, clear consensus is not available regarding
the optimal management of patients with this condition. Treatment strategies generally …

The clinical course, histopathology, and tumor DNA distribution patterns were analyzed in
95 patients with parathyroid cancer. The median follow-up was 6 years (range 1–25 years) …

Summary From 1948 to 1983, 28 patients with parathyroid carcinoma underwent treatment
and analysis at the Massachusetts General Hospital. This represents about 2 percent of the …

Parathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to
5% of primary hyperparathyroidism cases in various series. The cause is unknown, but …

A review of all reports in the literature of parathyroid carcinoma (PTC) was undertaken to
define an optimal management strategy for this rare condition. PTC is uncommon and its …

Hypothesis Reoperation is safe and benefits patients with persistent and recurrent
parathyroid carcinoma. Design Retrospective study. The mean follow-up time was 8.1 years …

Background The origin and molecular pathogenesis of parathyroid carcinoma are unknown.
This life-threatening cause of primary hyperparathyroidism cannot be reliably distinguished …